81
|
|
|
Cyclin dependent kinase inhibitor 2D |
INK4D, p19, p19-INK4D |
|
82
|
|
|
Cysteine rich secretory protein 3 |
Aeg2, CRISP-3, CRS3, SGP28, dJ442L6.3 |
|
83
|
|
|
Cyclin dependent kinase inhibitor 3 |
CDI1, CIP2, KAP, KAP1 |
|
84
|
|
|
Canopy FGF signaling regulator 2 |
HP10390, MSAP, TMEM4, ZSIG9 |
|
85
|
|
|
C-type lectin domain family 4 member M |
CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, L-SIGN, LSIGN |
|
86
|
|
|
Cysteine dioxygenase type 1 |
CDO-I |
|
87
|
|
|
Calcium voltage-gated channel auxiliary subunit gamma 2 |
MRD10 |
|
88
|
|
|
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 |
ASD8, MRG-1, MRG1, P35SRJ, VSD2 |
Atrial septal defect, Benign neoplasm, Brachydactyly, Camptodactyly of fingers, Cryptorchidism, Dolichocephaly, Heart septal defects, Malignant neoplasm, Neoplasms, Proptosis, Pulmonary venous return anomaly, Secundum atrial septal defect, Sinus venosus atrial septal defect, Situs inversus, Tetralogy of fallot, Ventricular septal defectView all (1 more) |
89
|
|
|
CCND2 antisense RNA 1 |
CCND2-AS2 |
|
90
|
|
|
Choline/ethanolamine phosphotransferase 1 |
- |
|